Half standard deviation estimate of the minimally important difference in HRQOL scores?

In addition to statistical significance, it is important to evaluate the magnitude of differences in health-related quality of life over time. Interest in establishing the minimal difference that is clinically important or the minimally important difference has burgeoned over the last few years. This review summarizes some of the leading approaches to estimating the minimally important difference, offers caveats on the minimally important difference estimation based on existing literature and provides recommendations for future work. The authors recommend using multiple anchors to estimate the minimally important difference, using only anchors that correspond to minimal change in health-related quality of life, reporting information about the variation around the estimates, and providing bounded estimates to reflect the uncertainty.

[1]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[2]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[3]  A R Nissenson,et al.  The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. , 1996, Journal of the American Society of Nephrology : JASN.

[4]  C. Seal,et al.  The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis , 2001, American Journal of Gastroenterology.

[5]  I. Wiklund,et al.  Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments , 2001, American Journal of Gastroenterology.

[6]  J. Brazier,et al.  What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.

[7]  D. Cella,et al.  What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. , 2002, Journal of clinical epidemiology.

[8]  E. Wise.  Methods for Analyzing Psychotherapy Outcomes: A Review of Clinical Significance, Reliable Change, and Recommendations for Future Directions , 2004, Journal of personality assessment.

[9]  Ronette L. Kolotkin,et al.  PQP3: DEFINING CLINICALLY MEANINGFUL CHANGE IN HEALTH-RELATED QUALITY OF LIFE , 2001 .

[10]  David Cella,et al.  Meaningful change in cancer-specific quality-of-life scores: Differences between improvement and worsening , 2002 .

[11]  G. Guyatt,et al.  Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ) , 1998, The European respiratory journal.

[12]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[13]  M. Decramer,et al.  Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.

[14]  T. Wagner,et al.  Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL) , 1999, Urology.

[15]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[16]  D. Tulsky,et al.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. , 1995, Lung cancer.

[17]  M. Drummond.  Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.

[18]  G. Guyatt,et al.  Randomized Controlled Trial of Respiratory Rehabilitation , 1995 .

[19]  J. Ware,et al.  Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[20]  G. Guyatt,et al.  Measuring quality of life in children with asthma , 1996, Quality of Life Research.

[21]  R. Kaplan.  The Minimally Clinically Important Difference in Generic Utility-Based Measures , 2005, COPD.

[22]  R. Hays,et al.  Responsiveness to change: an aspect of validity, not a separate dimension , 1992, Quality of Life Research.

[23]  Madeleine King,et al.  Estimating the Responsiveness of an Instrument Using More Than Two Repeated Measures , 2000, Biometrics.

[24]  S. Colletta,et al.  Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[26]  R. Keller,et al.  Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. , 1998, Medical care.

[27]  P. Tugwell,et al.  Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. , 1993, The Journal of rheumatology.

[28]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[29]  S. Ziebland,et al.  Importance of sensitivity to change as a criterion for selecting health status measures. , 1992, Quality in health care : QHC.

[30]  W F Lawrence,et al.  Predicting Quality of Well-being Scores from the SF-36 , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[32]  Andrew M Jones,et al.  Inequalities in self-reported health: validation of a new approach to measurement. , 2003, Journal of health economics.

[33]  J. Bernstein,et al.  Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[34]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[35]  D. Podzamczer,et al.  Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires , 2000, AIDS.

[36]  Richard V. Milani,et al.  Long-Term Benefits of Rehabilitation at Home on Quality of Life and Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease , 1996 .

[37]  J. Pyne,et al.  Comparing the Sensitivity of Generic Effectiveness Measures With Symptom Improvement in Persons With Schizophrenia , 2003, Medical care.

[38]  G. Stucki,et al.  Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. , 2002, The Journal of rheumatology.

[39]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[40]  F Angst,et al.  Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. , 2001, Arthritis and rheumatism.

[41]  J Zhang,et al.  What are minimal important changes for asthma measures in a clinical trial? , 1999, The European respiratory journal.

[42]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[43]  M. Hyland,et al.  A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. , 2001, Respiratory medicine.

[44]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[45]  Deborah M. Miller,et al.  Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. , 2000, Archives of neurology.